Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression‑free survival and overall survival versus standard of care regimens 83.3% of patients were alive at three years,… Read More
FRANKLIN LAKES, N.J. – BD a leading global medical technology company, announced it has obtained CE Marking for the Revello™ Vascular Covered Stent, a next-generation endovascular solution for the treatment… Read More
“I’ve been planting a lot of seeds and a lot of things are blooming,” says Marie-Ève Tremblay, Tier 1 Canada Research Chair in Neurobiology of Healthy Cognitive Aging and a professor in the… Read More
Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appeal If the $1.3 billion payment is… Read More
A new MedTech Dive article covers Labcorp’s expansion of its collaboration with PathAI to implement the FDA-cleared AISight® Dx digital pathology platform across its U.S. its national network of anatomic pathology labs… Read More
